| Affibody molecules in biotechnological and medical applications S Ståhl, T Gräslund, AE Karlström, FY Frejd, PÅ Nygren, J Löfblom Trends in biotechnology 35 (8), 691-712, 2017 | 392 | 2017 |
| Surface charge sensitivity of silicon nanowires: Size dependence N Elfström, R Juhasz, I Sychugov, T Engfeldt, AE Karlström, J Linnros Nano Letters 7 (9), 2608-2612, 2007 | 346 | 2007 |
| Silicon nanoribbons for electrical detection of biomolecules N Elfström, AE Karlström, J Linnros Nano letters 8 (3), 945-949, 2008 | 237 | 2008 |
| 99mTc-maEEE-ZHER2:342, an Affibody Molecule-Based Tracer for the Detection of HER2 Expression in Malignant Tumors T Tran, T Engfeldt, A Orlova, M Sandström, J Feldwisch, L Abrahmsén, ... Bioconjugate chemistry 18 (6), 1956-1964, 2007 | 139 | 2007 |
| Chemical synthesis of triple‐labelled three‐helix bundle binding proteins for specific fluorescent detection of unlabelled protein T Engfeldt, B Renberg, H Brumer, PÅ Nygren, A Eriksson Karlström Chembiochem 6 (6), 1043-1050, 2005 | 127 | 2005 |
| Imaging of HER2-expressing tumours using a synthetic Affibody molecule containing the 99mTc-chelating mercaptoacetyl-glycyl-glycyl-glycyl (MAG3) sequence T Engfeldt, A Orlova, T Tran, A Bruskin, C Widström, AE Karlström, ... European journal of nuclear medicine and molecular imaging 34, 722-733, 2007 | 123 | 2007 |
| 99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule T Engfeldt, T Tran, A Orlova, C Widström, J Feldwisch, L Abrahmsen, ... European journal of nuclear medicine and molecular imaging 34, 1843-1853, 2007 | 111 | 2007 |
| Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake T Ekblad, T Tran, A Orlova, C Widström, J Feldwisch, L Abrahmsén, ... European journal of nuclear medicine and molecular imaging 35, 2245-2255, 2008 | 97 | 2008 |
| Affibody molecules in protein capture microarrays: evaluation of multidomain ligands and different detection formats B Renberg, J Nordin, A Merca, M Uhlén, J Feldwisch, PÅ Nygren, ... Journal of proteome research 6 (1), 171-179, 2007 | 88 | 2007 |
| Affibody protein capture microarrays: synthesis and evaluation of random and directed immobilization of affibody molecules B Renberg, I Shiroyama, T Engfeldt, PÅ Nygren, AE Karlström Analytical biochemistry 341 (2), 334-343, 2005 | 85 | 2005 |
| In Vivo Evaluation of Cysteine-Based Chelators for Attachment of 99mTc to Tumor-Targeting Affibody Molecules T Tran, T Engfeldt, A Orlova, C Widström, A Bruskin, V Tolmachev, ... Bioconjugate chemistry 18 (2), 549-558, 2007 | 80 | 2007 |
| Feasibility of affibody molecule-based PNA-mediated radionuclide pretargeting of malignant tumors H Honarvar, K Westerlund, M Altai, M Sandström, A Orlova, V Tolmachev, ... Theranostics 6 (1), 93, 2016 | 70 | 2016 |
| Using antibody catalysis to study the outcome of multiple evolutionary trials of a chemical task A Karlstrom, G Zhong, C Rader, NA Larsen, A Heine, R Fuller, B List, ... Proceedings of the National Academy of Sciences 97 (8), 3878-3883, 2000 | 68 | 2000 |
| Ultra-localized single cell electroporation using silicon nanowires N Jokilaakso, E Salm, A Chen, L Millet, CD Guevara, B Dorvel, B Reddy, ... Lab on a Chip 13 (3), 336-339, 2013 | 66 | 2013 |
| Covalent immunoglobulin labeling through a photoactivable synthetic Z domain A Konrad, A Eriksson Karlström, S Hober Bioconjugate chemistry 22 (12), 2395-2403, 2011 | 66 | 2011 |
| A new protecting group for aspartic acid that minimizes piperidine-catalyzed aspartimide formation in Fmoc solid phase peptide synthesis A Karlström, A Undén Tetrahedron letters 37 (24), 4243-4246, 1996 | 65 | 1996 |
| Dual labeling of a binding protein allows for specific fluorescence detection of native protein A Karlström, PÅ Nygren Analytical biochemistry 295 (1), 22-30, 2001 | 61 | 2001 |
| Radionuclide therapy of HER2-expressing human xenografts using affibody-based peptide nucleic acid–mediated pretargeting: in vivo proof of principle K Westerlund, M Altai, B Mitran, M Konijnenberg, M Oroujeni, C Atterby, ... Journal of Nuclear Medicine 59 (7), 1092-1098, 2018 | 60 | 2018 |
| Feasibility of affibody-based bioorthogonal chemistry–mediated radionuclide pretargeting M Altai, A Perols, M Tsourma, B Mitran, H Honarvar, M Robillard, ... Journal of Nuclear Medicine 57 (3), 431-436, 2016 | 60 | 2016 |
| Effects of Lysine-Containing Mercaptoacetyl-Based Chelators on the Biodistribution of 99mTc-Labeled Anti-HER2 Affibody Molecules TA Tran, T Ekblad, A Orlova, M Sandstrom, J Feldwisch, A Wennborg, ... Bioconjugate chemistry 19 (12), 2568-2576, 2008 | 60 | 2008 |
